ट्रेड Novavax NVAX

बेचें
 खरीदें

Novavax लाइव चार्ट

5m 15m 30m 1h 4h 1d 1w

उपकरण मूल बातें

Weekly Search
Weekly
Daily
दिनांक बंद करें परिवर्तन (%) परिवर्तित करें खुला उच्च कम

Novavax news

2021 मई 11, 13:20

US pre-market: selling unabated

2021 मई 06, 08:27

Stocks rally as Fed speakers get back on script, earnings support + Bank of England set to raise forecasts

2021 Feb 28, 07:36

Week Ahead: RBA speaks, US NFPs released & OPEC clash

2020 मई 26, 08:04

Leg up: stocks make new ground, travel stocks soar

नवीनतम समाचार

और दिखाएं
Noah Lee 2025 Sep 25, 13:20

Xiaomi 17 Launch: Chip Strategy and Car Plans Unveiled

Liam James 2025 Sep 25, 12:20

Trump's Nobel Peace Prize Chances: Undermining International Order?

Ava Grace 2025 Sep 25, 09:20

White House Budget Office Directs Federal Agencies to Prepare for Mass Layoff Plans Amid Shutdown Fears

Liam James 2025 Sep 25, 09:20

Inflation Fears Grow: Is the US Economy Heading Towards Stagflation?

Sophia Claire 2025 Sep 25, 06:20

DoubleLine Capital Flags Concerns Over US Economic Data Quality, Turns to Alternative Sources

Liam James 2025 Sep 25, 04:20

Trump Shifts Ukraine Strategy: Pressure on Europe to Step Up

Sophia Claire 2025 Sep 25, 02:20

Trump Pledges to Arab Leaders He Won't Allow Israel to Annex West Bank

Ava Grace 2025 Sep 25, 01:20

Kremlin Dismisses Trump's Ukraine Stance Shift, Demands 'Real Information'

जानकारी

स्प्रेड

0.07

स्प्रेड (%)

0.8424 %

लीवरेज

1:10

ओवरनाइट ब्याज विक्रय

-0.0597 %

overnight_interest_sell

-0.0292 %

मुद्रा

USD

ट्रेडिंग घंटे

बाज़ार बंद है

शुक्रवार

13:31 - 19:59

सोमवार

13:31-19:59

मंगवार

13:31-19:59

बुधवार

13:31-19:59

गुरुवार

13:31-19:59

विश्लेषण और सांख्यिकी

खुला

---

पिछला बंद

---

52 सप्ताह उच्च/निम्न्च

--- – ---

बाज़ार आकार

1403323136

बकाया शेयर

162421645

प्राप्ति की तिथि (आगे)

2019-05-10

लाभांश आय 

2019-05-10

पूर्व-लाभांश तिथि

अग्रिम वार्षिक लाभांश दर 

0

अग्रिम वार्षिक लाभांश आय

0

EPS

2.22

इस उपकरण के बारे में अधिक जानें

Novavax Novavax Inc
Novavax, Inc., a biotechnology company, engages in the discovering, developing, and commercializing vaccines to protect against serious infectious diseases in the United States, Europe, and internationally. The company offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax COVID-19 Vaccine, adjuvanted for adult and adolescent populations as a primary series and for both homologous and heterologous booster indications. It also developing R21/Matrix-M adjuvant malaria vaccine. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.

संबंधित उपकरण

संपत्ति
बेचें
खरीदें
(%) परिवर्तित करें

अब ट्रेड करें

अब ट्रेड करें

अब ट्रेड करें

अब ट्रेड करें
view_all_instruments

latest_education_articles

और दिखाएं
Trustpilot